
    
      The REAL Registry will enroll a maximum of 3,000 patients in approximately 300 sites across
      multiple European and Middle East countries, where product has received CE approval and is
      marketed. An average of 10 cases with a maximum of 50 patients will be enrolled per
      participating site.

      No follow-up will be performed. The REAL Registry will only collect data during diagnostic
      angiogram or PCI procedure, when performed.
    
  